drugset / Trial / NCT00606203

Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?

NCT00606203

Unknown 120 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

Depression is one of the important psychiatric sequelae after stroke. The prevalence of post stroke depression (PSD) is approximately 20-40%. Depression comorbid with stroke has been found to be associated with increased disability, cognitive function decline, poorer rehabilitation outcome and higher mortality rate.We are going to conduct a trial of prevention of psot stroke depression by prescribing milnacipran in advance.

Timeline

Start
2007-09
Primary completion
2010-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified 50 mg